- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Report
- December 2021
- 95 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Drug Pipelines
- December 2019
- 27 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Drug Pipelines
- October 2018
- 62 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Book
- August 2019
- 416 Pages
- Book
- July 2009
- 620 Pages
- Book
- September 2020
- 560 Pages
Reductases are a type of enzyme that catalyze the reduction of a wide variety of substrates, including organic molecules, metals, and other compounds. They are involved in a variety of metabolic pathways, including the reduction of nitrate to nitrite, the reduction of sulfate to sulfide, and the reduction of carbon dioxide to formic acid. Reductases are also used in the production of pharmaceuticals, food additives, and other industrial products.
The reductase market is a rapidly growing sector of the enzyme industry. It is driven by the increasing demand for enzymes in the pharmaceutical, food, and industrial sectors. The market is expected to continue to grow as new applications for reductases are discovered.
Some companies in the reductase market include Novozymes, Merck KGaA, Sigma-Aldrich, and Roche. Show Less Read more